Literature DB >> 35968351

The functions and prognostic values of chemokine and chemokine receptors in gastric cancer.

Chenglong He1, Liping He2, Qiaowei Lu1, Jianjun Xiao1, Wenjing Dong1.   

Abstract

Chemokine and chemokine receptors (CCRs) play a significant role in tumor infiltration of immune cells, tumor angiogenesis and distant metastasis. In this study, we explored the importance of CCRs in gastric cancer (GC) by analyzing the datasets from TCGA database. First, we analyzed the characteristics of the CCRs mutations. Then, we screened the differentially expressed CCRs and performed GO functional annotation and KEGG pathway analyses to explore their potential biological functions. Using multivariate Cox regression analyses, we constructed a prediction model based on four-CCRs (CCL15, CCL21, CCR3 and ACKR3) signature, and we found that the risk score of the model was an independent prognostic factor of GC. Next, a nomogram was constructed to assess the prognosis of GC patients. GSEA indicated that the high-risk group was significantly enriched in immune response and immune system process. Moreover, GSVA was employed to investigate the up- and down-regulated signaling pathways in the high- and low-risk groups. The correlation between risk score and immune-cell infiltration indicated that the four-CCRs signature might play a pivotal role in GC immune microenvironment. In conclusion, we revealed the potential molecular mechanisms of CCRs in GC and constructed a prediction model which might guide personalized treatment and prognosis for GC patients. AJCR
Copyright © 2022.

Entities:  

Keywords:  Chemokine; chemokine receptors; gastric cancer; immune infiltrates; prognosis

Year:  2022        PMID: 35968351      PMCID: PMC9360243     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  61 in total

1.  Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.

Authors:  Jungsu Hwang; Chan Woo Kim; Kyung-No Son; Kyu Yeon Han; Kyung Hee Lee; Hynda K Kleinman; Jesang Ko; Doe Sun Na; Byoung S Kwon; Yong Song Gho; Jiyoung Kim
Journal:  FEBS Lett       Date:  2004-07-16       Impact factor: 4.124

2.  Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines.

Authors:  F Coulin; C A Power; S Alouani; M C Peitsch; J M Schroeder; M Moshizuki; I Clark-Lewis; T N Wells
Journal:  Eur J Biochem       Date:  1997-09-01

Review 3.  The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.

Authors:  Christelle Freitas; Aude Desnoyer; Floriane Meuris; Françoise Bachelerie; Karl Balabanian; Véronique Machelon
Journal:  Cytokine Growth Factor Rev       Date:  2014-05-09       Impact factor: 7.638

4.  HCC-2, a human chemokine: gene structure, expression pattern, and biological activity.

Authors:  A Pardigol; U Forssmann; H D Zucht; P Loetscher; P Schulz-Knappe; M Baggiolini; W G Forssmann; H J Mägert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Atae Utsunomiya; Yoshitaka Inoue; Takashi Miyagi; Satsuki Owatari; Yasushi Sawayama; Yukiyoshi Moriuchi; Ilseung Choi; Takero Shindo; Shin-Ichiro Yoshida; Satoshi Yamasaki; Takuhiro Yamaguchi; Takahiro Fukuda
Journal:  Haematologica       Date:  2018-01-25       Impact factor: 9.941

Review 6.  The chemokine superfamily revisited.

Authors:  Albert Zlotnik; Osamu Yoshie
Journal:  Immunity       Date:  2012-05-25       Impact factor: 31.745

7.  CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2.

Authors:  S Wu; X Lu; Z L Zhang; P Lei; P Hu; M Wang; B Huang; W Xing; X T Jiang; H J Liu; Z G Zhu; W H Li; H F Zhu; N Fu; G X Shen
Journal:  Carcinogenesis       Date:  2010-12-13       Impact factor: 4.944

8.  Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.

Authors:  Kenneth J Pienta; Jean-Pascal Machiels; Dirk Schrijvers; Boris Alekseev; Mikhail Shkolnik; Simon J Crabb; Susan Li; Shobha Seetharam; Thomas A Puchalski; Chris Takimoto; Yusri Elsayed; Fitzroy Dawkins; Johann S de Bono
Journal:  Invest New Drugs       Date:  2012-08-21       Impact factor: 3.850

9.  3,3'-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs.

Authors:  Hui Shi; Yaoxiang Sun; Hongru Ruan; Cheng Ji; Jiahui Zhang; Peipei Wu; Linli Li; Chihan Huang; Yuanwang Jia; Xu Zhang; Wenrong Xu; Jiajia Jiang; Hui Qian
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

10.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration.

Authors:  Andrea Franceschini; Damian Szklarczyk; Sune Frankild; Michael Kuhn; Milan Simonovic; Alexander Roth; Jianyi Lin; Pablo Minguez; Peer Bork; Christian von Mering; Lars J Jensen
Journal:  Nucleic Acids Res       Date:  2012-11-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.